Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  cabazitaxel
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Enzalutamide and Cabazitaxel in Treating Patients with Metastatic, Castration-Resistant Prostate Cancer
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: IRB00011227, NCI-2015-01103, 11227, CRS00001390, NCT02522715
Abiraterone Acetate with or without Cabazitaxel in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-046, NCI-2014-01894, c12-108, NCT02218606
Cabazitaxel and Prednisone in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UCDCC#261, NCI-2016-00961, NCT02844582
Rapid Cycle Combination Therapy in Treating Patients with Metastatic Castrate-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: Any age
Trial IDs: 16-1593, NCI-2017-00934, NCT02903160
Cabazitaxel, Mitoxantrone Hydrochloride, and Prednisone in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 11951, NCI-2014-01725, 086396, 46001, CC#11951, NCI-2014-00725, UCSF Protocol No. 11951, NCT01594918
Cabazitaxel, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients with BCG Solution-Refractory Non-muscle Invasive Urothelial Carcinoma of the Bladder
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: AAAM8506, NCI-2015-00757, NCT02202772
Start Over